Heart Failure in Diabetes Mellitus: the Pathogenesis and Treatment

Yiyang Xu

doi:10.54254/2753-8818/2024.17985

Research Article

Open access

Published on 6 December 2024

Download pdf

Xu,Y. (2024). Heart Failure in Diabetes Mellitus: the Pathogenesis and Treatment. Theoretical and Natural Science,64,81-86.

Export citation

Heart Failure in Diabetes Mellitus: the Pathogenesis and Treatment

Yiyang Xu *^,1,

¹ Xuzhou Medical University

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2753-8818/2024.17985

Abstract

People with diabetes mellitus are more likely to develop heart failure, and those with both conditions often experience a worse prognosis compared to heart failure patients without diabetes. This paper will summarize the pathogenesis of diabetic heart failure and propose treatment and prevention options for diabetic patients with heart failure based on the existing literature and data results. Both types of diabetes lead to high blood sugar levels, which, along with diabetes itself, exert different effects on the heart. As time goes on, it causes heart failure. The outcome demonstrates how chronically elevated blood sugar levels can lead to inflammation and accelerate the development of heart failure. Significant roles are also played by oxidative damage, insulin resistance, and other variables. It has been demonstrated that altering one's lifestyle can avoid diabetic heart failure and improve the quality of life for individuals with asymptomatic diastolic dysfunction and heart failure with preserved ejection fraction (HFpEF).

Keywords

Diabetes Mellitus, Heart failure, Diabetic cardiomyopathy, Cardiovascular diseases, Metabolic disease, pathogenesis

View pdf

References

[1]. Jia, G., DeMarco, V. G., & Sowers, J. R. (2016). Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nature Reviews Endocrinology, 12(3), 144–153. https://doi.org/10.1038/nrendo.2015.216

[2]. Kenny, H. C., & Abel, E. D. (2020). Heart Failure in Type 2 Diabetes Mellitus: Impact of Glucose Lowering Agents, Heart Failure Therapies and Novel Therapeutic Strategies.

[3]. Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Groop, P.-H., Handelsman, Y., Insel, R. A., Mathieu, C., McElvaine, A. T., Palmer, J. P., Pugliese, A., Schatz, D. A., Sosenko, J. M., Wilding, J. P. H., & Ratner, R. E. (2017). Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis. Diabetes, 66(2), 241–255. https://doi.org/10.2337/db16-0806

[4]. Schwinger, R. H. G. (2021). Pathophysiology of heart failure. Cardiovascular Diagnosis and Therapy, 11(1), 263–276. https://doi.org/10.21037/cdt-20-302

[5]. Kenny, H. C., & Abel, E. D. (2020). Heart Failure in Type 2 Diabetes Mellitus: Impact of Glucose Lowering Agents, Heart Failure Therapies and Novel Therapeutic Strategies.

[6]. Junlin Qiu, Shuoming Luo&Zhiguang Zhou. (2020). Research progress of diabetic heart disease. Chinese Journal of Arteriosclerosis(08), 679-687

[7]. Ritchie, R. H., & Abel, E. D. (2020). Basic Mechanisms of Diabetic Heart Disease. Circulation Research, 126(11), 1501–1525. https://doi.org/10.1161/CIRCRESAHA.120.315913

[8]. Jia, G., DeMarco, V. G., & Sowers, J. R. (2016). Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nature Reviews Endocrinology, 12(3), 144–153. https://doi.org/10.1038/nrendo.2015.216

[9]. Jankauskas, S. S., Kansakar, U., Varzideh, F., Wilson, S., Mone, P., Lombardi, A., Gambardella, J., & Santulli, G. (2021). Heart failure in diabetes. Metabolism, 125, 154910. https://doi.org/10.1016/j.metabol.2021.154910

[10]. Wang, L., Cai, Y., Jian, L., Cheung, C. W., Zhang, L., & Xia, Z. (2021). Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy. Cardiovascular Diabetology, 20(1), 2. https://doi.org/10.1186/s12933-020-01188-0

[11]. Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022). Inflammation in obesity, diabetes, and related disorders. Immunity, 55(1), 31–55. https://doi.org/10.1016/j.immuni.2021.12.013

[12]. Darenskaya, M. A., Kolesnikova, L. I., & Kolesnikov, S. I. (2021). Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to Correction. Bulletin of Experimental Biology and Medicine, 171(2), 179–189. https://doi.org/10.1007/s10517-021-05191-7

[13]. Tsutsui, H., Kinugawa, S., & Matsushima, S. (2011). Oxidative stress and heart failure. 301.

[14]. Nakamura, K., Miyoshi, T., Yoshida, M., Akagi, S., Saito, Y., Ejiri, K., Matsuo, N., Ichikawa, K., Iwasaki, K., Naito, T., Namba, Y., Yoshida, M., Sugiyama, H., & Ito, H. (2022). Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus. Int. J. Mol. Sci.

[15]. Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Journal of the American College of Cardiology, 74(10), e177–e232. https://doi.org/10.1016/j.jacc.2019.03.010

Cite this article

Xu,Y. (2024). Heart Failure in Diabetes Mellitus: the Pathogenesis and Treatment. Theoretical and Natural Science,64,81-86.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science

Conference website: https://2024.icbiomed.org/

ISBN：978-1-83558-731-7(Print) / 978-1-83558-732-4(Online)

Conference date: 25 October 2024

Editor：Alan Wang

Series: Theoretical and Natural Science

Volume number: Vol.64

ISSN：2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).